Mayaro: an emerging viral threat?

Mayaro virus (MAYV), an enveloped RNA virus, belongs to the Togaviridae family and Alphavirus genus. This arthropod-borne virus (Arbovirus) is similar to Chikungunya (CHIKV), Dengue (DENV), and Zika virus (ZIKV). The term “ChikDenMaZika syndrome” has been coined for clinically suspected arboviruses,...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2018
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23916
Acceso en línea:
https://doi.org/10.1038/s41426-018-0163-5
https://repository.urosario.edu.co/handle/10336/23916
Palabra clave:
Alphavirus
Arbovirus
Arthralgia
Bleeding
Chikungunya virus
Cross reaction
Dengue virus
Fever
Genomics
Human
Life threat
Maculopapular rash
Mayaro virus
Mixed infection
Myocarditis
Neurological complication
Nonhuman
Polyarthritis
Priority journal
Review
South America
Togaviridae
Virus load
Virus morphology
Zika virus
Alphavirus infection
Animal
Classification
Communicable disease
Genetics
Isolation and purification
Physiology
Virology
Alphavirus
Alphavirus Infections
Animals
Humans
South America
Emerging
Communicable Diseases
Rights
License
Abierto (Texto Completo)
Description
Summary:Mayaro virus (MAYV), an enveloped RNA virus, belongs to the Togaviridae family and Alphavirus genus. This arthropod-borne virus (Arbovirus) is similar to Chikungunya (CHIKV), Dengue (DENV), and Zika virus (ZIKV). The term “ChikDenMaZika syndrome” has been coined for clinically suspected arboviruses, which have arisen as a consequence of the high viral burden, viral co-infection, and co-circulation in South America. In most cases, MAYV disease is nonspecific, mild, and self-limited. Fever, arthralgia, and maculopapular rash are among the most common symptoms described, being largely indistinguishable from those caused by other arboviruses. However, severe manifestations of the infection have been reported, such as chronic polyarthritis, neurological complications, hemorrhage, myocarditis, and even death. Currently, there are no specific commercial tools for the diagnosis of MAYV, and the use of serological methods can be affected by cross-reactivity and the window period. A diagnosis based on clinical and epidemiological data alone is still premature. Therefore, new entomological research is warranted, and new highly specific molecular diagnostic methods should be developed. This comprehensive review is intended to encourage public health authorities and scientific communities to actively work on diagnosing, preventing, and treating MAYV infection. © 2018, The Author(s).